MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer

NCT04078269 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

BIOLOGICAL: Dendritic cell immunotherapy
BIOLOGICAL: Antigen-specific DTH
BIOLOGICAL: Control DTH

Sponsor

University Hospital, Ghent

Collaborators

[object Object]
[object Object]